oligonucleotide therapeutic development: pre-clinical and translational considerations
Published 3 years ago • 727 plays • Length 25:00Download video MP4
Download video MP3
Similar videos
-
25:20
oligonucleotide therapeutic development: clinical pharmacology considerations
-
9:25
what are oligonucleotide therapeutics, and how do they work?
-
1:07:07
submerge in the oligonucleotide emerge: best practices for developing these complex biologics
-
6:17
best practices for oligonucleotide therapeutic development: q&a
-
32:40
scientific symposium 303 preclinical and clinical development of oligonucleotide therapies organi
-
22:47
chemistry of oligonucleotide therapeutics 101
-
14:55
oligonucleotide manufacturing facilities
-
2:13
fixing genes with antisense oligonucleotides (asos)
-
1:04:31
antisense oligonucleotide based therapies for inherited retinal diseases from mutation to clinical
-
31:01
addressing delivery hurdles in the translation of oligonucleotide therapeutics
-
1:42
oligonucleotide-based therapeutics
-
1:05
how does it work? | antisense oligonucleotide therapy
-
59:22
delivery of chemically stabilized rnai molecules to the central nervous system
-
13:49
oligonucleotide therapeutics: new drugs that could stop covid-19
-
1:35
types of oligonucleotides
-
54:11
shalini andersson: developing oligonucleotides into therapies
-
1:01:28
chemical and nanotechnology based approaches to build next gen oligonucleotide therapeutics
-
35:00
quantification methods for oligonucleotide therapeutics in serum and tissue
-
33:21
chemistry of therapeutic oligonucleotides: a brief overview
-
23:23
oligonucleotides as a new therapeutic class: progress report & prescription